Physiol Rev AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Physiol. Rev. 78: 189-225, 1998;
0031-9333/98 $15.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MISSALE, C.
Right arrow Articles by CARON, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MISSALE, C.
Right arrow Articles by CARON, M. G.

PHYSIOLOGICAL REVIEWS   Vol. 78 No. 1 January 1998, pp. 189-225
Copyright ©1998 The American Physiological Society

Dopamine Receptors: From Structure to Function

CRISTINA MISSALE, S. RUSSEL NASH, SUSAN W. ROBINSON, MOHAMED JABER, AND MARC G. CARON

Departments of Cell Biology and Medicine, Howard Hughes Medical Institute Laboratories, Duke University Medical Center, Durham, North Carolina

Missale, Cristina, S. Russel Nash, Susan W. Robinson, Mohamed Jaber, and Marc G. Caron. Dopamine Receptors: From Structure to Function. Physiol. Rev. 78: 189-225, 1998. --- The diverse physiological actions of dopamine are mediated by at least five distinct G protein-coupled receptor subtypes. Two D1-like receptor subtypes (D1 and D5) couple to the G protein Gs and activate adenylyl cyclase. The other receptor subtypes belong to the D2-like subfamily (D2 , D3 , and D4) and are prototypic of G protein-coupled receptors that inhibit adenylyl cyclase and activate K+ channels. The genes for the D1 and D5 receptors are intronless, but pseudogenes of the D5 exist. The D2 and D3 receptors vary in certain tissues and species as a result of alternative splicing, and the human D4 receptor gene exhibits extensive polymorphic variation. In the central nervous system, dopamine receptors are widely expressed because they are involved in the control of locomotion, cognition, emotion, and affect as well as neuroendocrine secretion. In the periphery, dopamine receptors are present more prominently in kidney, vasculature, and pituitary, where they affect mainly sodium homeostasis, vascular tone, and hormone secretion. Numerous genetic linkage analysis studies have failed so far to reveal unequivocal evidence for the involvement of one of these receptors in the etiology of various central nervous system disorders. However, targeted deletion of several of these dopamine receptor genes in mice should provide valuable information about their physiological functions.




This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
C. Fiorentini, C. Busi, E. Gorruso, C. Gotti, P. Spano, and C. Missale
Reciprocal Regulation of Dopamine D1 and D3 Receptor Function and Trafficking by Heterodimerization
Mol. Pharmacol., July 1, 2008; 74(1): 59 - 69.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Iwakura, H. Nawa, I. Sora, and M. V. Chao
Dopamine D1 Receptor-induced Signaling through TrkB Receptors in Striatal Neurons
J. Biol. Chem., June 6, 2008; 283(23): 15799 - 15806.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
S. Koyanagi, S. Himukashi, K. Mukaida, T. Shichino, and K. Fukuda
Dopamine D2-Like Receptor in the Nucleus Accumbens Is Involved in the Antinociceptive Effect of Nitrous Oxide
Anesth. Analg., June 1, 2008; 106(6): 1904 - 1909.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. Benchoua, Y. Trioulier, E. Diguet, C. Malgorn, M.-C. Gaillard, N. Dufour, J.-M. Elalouf, S. Krajewski, P. Hantraye, N. Deglon, et al.
Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II
Hum. Mol. Genet., May 15, 2008; 17(10): 1446 - 1456.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
A. Fusco, G. Gunz, P. Jaquet, H. Dufour, A. L. Germanetti, M. D Culler, A. Barlier, and A. Saveanu
Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas
Eur. J. Endocrinol., May 1, 2008; 158(5): 595 - 603.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
T. Del'guidice and J.-M. Beaulieu
Messing Up with Traffic: Different Effects of Antipsychotic Agents on Glutamate Receptor Complexes in Vivo
Mol. Pharmacol., May 1, 2008; 73(5): 1339 - 1342.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Rondou, G. Haegeman, P. Vanhoenacker, and K. Van Craenenbroeck
BTB Protein KLHL12 Targets the Dopamine D4 Receptor for Ubiquitination by a Cul3-based E3 Ligase
J. Biol. Chem., April 25, 2008; 283(17): 11083 - 11096.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. E. Gonzalez-Iglesias, T. Murano, S. Li, M. Tomic, and S. S. Stojilkovic
Dopamine Inhibits Basal Prolactin Release in Pituitary Lactotrophs through Pertussis Toxin-Sensitive and -Insensitive Signaling Pathways
Endocrinology, April 1, 2008; 149(4): 1470 - 1479.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. K. Towers and S. Hestrin
D1-Like Dopamine Receptor Activation Modulates GABAergic Inhibition But Not Electrical Coupling between Neocortical Fast-Spiking Interneurons
J. Neurosci., March 5, 2008; 28(10): 2633 - 2641.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee
What Can We Learn from Rodents about Prolactin in Humans?
Endocr. Rev., February 1, 2008; 29(1): 1 - 41.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. J. Gildea, X. Wang, P. A. Jose, and R. A. Felder
Differential D1 and D5 Receptor Regulation and Degradation of the Angiotensin Type 1 Receptor
Hypertension, February 1, 2008; 51(2): 360 - 366.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
L. Orozco-Cabal, J. Liu, S. Pollandt, K. Schmidt, P. Shinnick-Gallagher, and J. P. Gallagher
Dopamine and Corticotropin-Releasing Factor Synergistically Alter Basolateral Amygdala-to-Medial Prefrontal Cortex Synaptic Transmission: Functional Switch after Chronic Cocaine Administration
J. Neurosci., January 9, 2008; 28(2): 529 - 542.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
B. J. Aragona and Z. Wang
Opposing Regulation of Pair Bond Formation by cAMP Signaling within the Nucleus Accumbens Shell
J. Neurosci., November 28, 2007; 27(48): 13352 - 13356.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Kitaoka, T. Furuyashiki, A. Nishi, T. Shuto, S. Koyasu, T. Matsuoka, M. Miyasaka, P. Greengard, and S. Narumiya
Prostaglandin E2 Acts on EP1 Receptor and Amplifies Both Dopamine D1 and D2 Receptor Signaling in the Striatum
J. Neurosci., November 21, 2007; 27(47): 12900 - 12907.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
Y. Iizuka, Y. Sei, D. R. Weinberger, and R. E. Straub
Evidence That the BLOC-1 Protein Dysbindin Modulates Dopamine D2 Receptor Internalization and Signaling But Not D1 Internalization
J. Neurosci., November 7, 2007; 27(45): 12390 - 12395.
[Abstract] [Full Text] [PDF]

Home page
 Hum Exp ToxicolHome page
S. Kim, J. Nam, and K. Kim
Aluminum exposure decreases dopamine D1 and D2 receptor expression in mouse brain
Human and Experimental Toxicology, September 1, 2007; 26(9): 741 - 746.
[Abstract] [PDF]

Home page
 Mol. Endocrinol.Home page
E.-Y. Cho, D.-I. Cho, J. H. Park, H. Kurose, M. G. Caron, and K.-M. Kim
Roles of Protein Kinase C and Actin-Binding Protein 280 in the Regulation of Intracellular Trafficking of Dopamine D3 Receptor
Mol. Endocrinol., September 1, 2007; 21(9): 2242 - 2254.
[Abstract] [Full Text] [PDF]

Home page
 Schizophr BullHome page
R. W. Buchanan, R. Freedman, D. C. Javitt, A. Abi-Dargham, and J. A. Lieberman
Recent Advances in the Development of Novel Pharmacological Agents for the Treatment of Cognitive Impairments in Schizophrenia
Schizophr Bull, September 1, 2007; 33(5): 1120 - 1130.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. A. Banday, F. R. Fazili, and M. F. Lokhandwala
Insulin causes renal dopamine D1 receptor desensitization via GRK2-mediated receptor phosphorylation involving phosphatidylinositol 3-kinase and protein kinase C
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F877 - F884.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
K.-H. Huemer, C. Zawinka, G. Garhofer, E. Golestani, B. Litschauer, G. T Dorner, and L. Schmetterer
Effects of dopamine on retinal and choroidal blood flow parameters in humans
Br. J. Ophthalmol., September 1, 2007; 91(9): 1194 - 1198.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
T.-S. Tang, X. Chen, J. Liu, and I. Bezprozvanny
Dopaminergic Signaling and Striatal Neurodegeneration in Huntington's Disease
J. Neurosci., July 25, 2007; 27(30): 7899 - 7910.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. B. Free, L. A. Hazelwood, D. M. Cabrera, H. N. Spalding, Y. Namkung, M. L. Rankin, and D. R. Sibley
D1 and D2 Dopamine Receptor Expression Is Regulated by Direct Interaction with the Chaperone Protein Calnexin
J. Biol. Chem., July 20, 2007; 282(29): 21285 - 21300.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Rogaeva, X.-M. Ou, H. Jafar-Nejad, S. Lemonde, and P. R. Albert
Differential Repression by Freud-1/CC2D1A at a Polymorphic Site in the Dopamine-D2 Receptor Gene
J. Biol. Chem., July 20, 2007; 282(29): 20897 - 20905.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Y. Inoue, L. Yao, F. W. Hopf, P. Fan, Z. Jiang, A. Bonci, and I. Diamond
Nicotine and Ethanol Activate Protein Kinase A Synergistically via Gi beta{gamma} Subunits in Nucleus Accumbens/Ventral Tegmental Cocultures: The Role of Dopamine D1/D2 and Adenosine A2A Receptors
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 23 - 29.
[Abstract] [Full Text] [PDF]

Home page
 Schizophr BullHome page
S. R. Laviolette
Dopamine Modulation of Emotional Processing in Cortical and Subcortical Neural Circuits: Evidence for a Final Common Pathway in Schizophrenia?
Schizophr Bull, July 1, 2007; 33(4): 971 - 981.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. A. Banday and M. F. Lokhandwala
Oxidative stress reduces renal dopamine D1 receptor-Gq/11{alpha} G protein-phospholipase C signaling involving G protein-coupled receptor kinase 2
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F306 - F315.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
D. C. Rotaru, D. A. Lewis, and G. Gonzalez-Burgos
Dopamine D1 receptor activation regulates sodium channel-dependent EPSP amplification in rat prefrontal cortex pyramidal neurons
J. Physiol., June 15, 2007; 581(3): 981 - 1000.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
F. Tecuapetla, L. Carrillo-Reid, J. Bargas, and E. Galarraga
Dopaminergic modulation of short-term synaptic plasticity at striatal inhibitory synapses
PNAS, June 12, 2007; 104(24): 10258 - 10263.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Zhang, A. Vinuela, M. H. Neely, P. J. Hallett, S. G. N. Grant, G. M. Miller, O. Isacson, M. G. Caron, and W.-D. Yao
Inhibition of the Dopamine D1 Receptor Signaling by PSD-95
J. Biol. Chem., May 25, 2007; 282(21): 15778 - 15789.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Bontempi, C. Fiorentini, C. Busi, N. Guerra, P. Spano, and C. Missale
Identification and Characterization of Two Nuclear Factor-{kappa}B Sites in the Regulatory Region of the Dopamine D2 Receptor
Endocrinology, May 1, 2007; 148(5): 2563 - 2570.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
L. Brusa, F. Petta, A. Pisani, V. Moschella, C. Iani, P. Stanzione, R. Miano, and E. Finazzi-Agro
Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease
Neurology, May 1, 2007; 68(18): 1455 - 1459.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. A. Banday, F. R. Fazili, and M. F. Lokhandwala
Oxidative Stress Causes Renal Dopamine D1 Receptor Dysfunction and Hypertension via Mechanisms That Involve Nuclear Factor-{kappa}B and Protein Kinase C
J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1446 - 1457.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. A. Al-Fulaij, Y. Ren, M. Beinborn, and A. S. Kopin
Identification of Amino Acid Determinants of Dopamine 2 Receptor Synthetic Agonist Function
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 298 - 307.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
R. Pivonello, D. Ferone, G. Lombardi, A. Colao, S. W J Lamberts, and L. J Hofland
Novel insights in dopamine receptor physiology
Eur. J. Endocrinol., April 1, 2007; 156(suppl_1): S13 - S21.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
D. Ferone, R. Pivonello, E. Resmini, M. Boschetti, A. Rebora, M. Albertelli, V. Albanese, A. Colao, M. D Culler, and F. Minuto
Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas
Eur. J. Endocrinol., April 1, 2007; 156(suppl_1): S37 - S43.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
A. Colao, M. Filippella, R. Pivonello, C. Di Somma, A. Faggiano, and G. Lombardi
Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours
Eur. J. Endocrinol., April 1, 2007; 156(suppl_1): S57 - S63.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Z. Zheng and R. A. Travagli
Dopamine effects on identified rat vagal motoneurons
Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1002 - G1008.
[Abstract] [Full Text] [PDF]

Home page
 Hum Exp ToxicolHome page
N Basu, A M Scheuhammer, R D Evans, M O'Brien, and H M Chan
Cholinesterase and monoamine oxidase activity in relation to mercury levels in the cerebral cortex of wild river otters
Human and Experimental Toxicology, March 1, 2007; 26(3): 213 - 220.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
B. W. Dunlop and C. B. Nemeroff
The Role of Dopamine in the Pathophysiology of Depression
Arch Gen Psychiatry, March 1, 2007; 64(3): 327 - 337.
[Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Z.-Q. Wu, J. Chen, Z.-Q. Chi, and J.-G. Liu
Involvement of Dopamine System in Regulation of Na+,K+-ATPase in the Striatum upon Activation of Opioid Receptors by Morphine
Mol. Pharmacol., February 1, 2007; 71(2): 519 - 530.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J.-M. Beaulieu, E. Tirotta, T. D. Sotnikova, B. Masri, A. Salahpour, R. R. Gainetdinov, E. Borrelli, and M. G. Caron
Regulation of Akt Signaling by D2 and D3 Dopamine Receptors In Vivo
J. Neurosci., January 24, 2007; 27(4): 881 - 885.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Pivonello, D. Ferone, W. W. de Herder, A. Faggiano, L. Bodei, R. R. de Krijger, G. Lombardi, A. Colao, S. W. J. Lamberts, and L. J. Hofland
Dopamine Receptor Expression and Function in Corticotroph Ectopic Tumors
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 65 - 69.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. K. Aman, R.-Y. Shen, and S. Haj-Dahmane
D2-Like Dopamine Receptors Depolarize Dorsal Raphe Serotonin Neurons through the Activation of Nonselective Cationic Conductance
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 376 - 385.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. Zhang, L. Zhang, H. Jiao, Q. Zhang, D. Zhang, D. Lou, J. L. Katz, and M. Xu
c-Fos Facilitates the Acquisition and Extinction of Cocaine-Induced Persistent Changes
J. Neurosci., December 20, 2006; 26(51): 13287 - 13296.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. Cui, M. Xu, and M. Atzori
Voltage-Dependent Block of N-Methyl-D-aspartate Receptors by Dopamine D1 Receptor Ligands
Mol. Pharmacol., November 1, 2006; 70(5): 1761 - 1770.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
P. Kok, F. Roelfsema, M. Frolich, J. van Pelt, M. P. M. Stokkel, A. E. Meinders, and H. Pijl
Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women
Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1038 - E1043.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-M. Beaulieu, T. D. Sotnikova, R. R. Gainetdinov, and M. G. Caron
Paradoxical Striatal Cellular Signaling Responses to Psychostimulants in Hyperactive Mice
J. Biol. Chem., October 27, 2006; 281(43): 32072 - 32080.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C. O. Alberto, R. B. Trask, M. E. Quinlan, and M. Hirasawa
Bidirectional Dopaminergic Modulation of Excitatory Synaptic Transmission in Orexin Neurons
J. Neurosci., September 27, 2006; 26(39): 10043 - 10050.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
I. Garcia-Tornadu, M. Rubinstein, B. D Gaylinn, D. Hill, E. Arany, M. J Low, G. Diaz-Torga, and D. Becu-Villalobos
GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin.
J. Endocrinol., September 1, 2006; 190(3): 611 - 619.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. de Guise, A. Lacerte, S. Rafiei, R. Reynaud, M. Roy, T. Brue, and J.-J. Lebrun
Activin Inhibits the Human Pit-1 Gene Promoter through the p38 Kinase Pathway in a Smad-Independent Manner
Endocrinology, September 1, 2006; 147(9): 4351 - 4362.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
J. ZHANG and M. XU
Opposite regulation of cocaine-induced intracellular signaling and gene expression by dopamine D1 and D3 receptors.
Ann. N.Y. Acad. Sci., August 1, 2006; 1074: 1 - 12.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
Y. Asaumi, H. Hasuo, and T. Akasu
Dopamine Presynaptically Depresses Fast Inhibitory Synaptic Transmission via D4 Receptor-Protein Kinase A Pathway in the Rat Dorsolateral Septal Nucleus
J Neurophysiol, August 1, 2006; 96(2): 591 - 601.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. P. Gillam, M. E. Molitch, G. Lombardi, and A. Colao
Advances in the Treatment of Prolactinomas
Endocr. Rev., August 1, 2006; 27(5): 485 - 534.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Biol.Home page
G. Genovese, M. Senek, N. Ortiz, M. Regueira, D. W. Towle, M. Tresguerres, and C. M. Luquet
Dopaminergic regulation of ion transport in gills of the euryhaline semiterrestrial crab Chasmagnathus granulatus: interaction between D1- and D2-like receptors
J. Exp. Biol., July 15, 2006; 209(14): 2785 - 2793.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. M. C. Kong, T. Fan, G. Varghese, B. F. O'Dowd, and S. R. George
Agonist-Induced Cell Surface Trafficking of an Intracellularly Sequestered D1 Dopamine Receptor Homo-Oligomer
Mol. Pharmacol., July 1, 2006; 70(1): 78 - 89.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
A. Li, H. Guo, X. Luo, J. Sheng, S. Yang, Y. Yin, J. Zhou, and J. Zhou
Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons
FASEB J, June 1, 2006; 20(8): 1263 - 1265.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
I. Yujnovsky, J. Hirayama, M. Doi, E. Borrelli, and P. Sassone-Corsi
Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1
PNAS, April 18, 2006; 103(16): 6386 - 6391.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. N. Helms, X.-J. Chen, S. Ramosevac, D. C. Eaton, and L. Jain
Dopamine regulation of amiloride-sensitive sodium channels in lung cells
Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L710 - L722.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. L. Rankin, P. S. Marinec, D. M. Cabrera, Z. Wang, P. A. Jose, and D. R. Sibley
The D1 Dopamine Receptor Is Constitutively Phosphorylated by G Protein-Coupled Receptor Kinase 4
Mol. Pharmacol., March 1, 2006; 69(3): 759 - 769.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. Fiorentini, M. C. Rizzetti, C. Busi, S. Bontempi, G. Collo, P. Spano, and C. Missale
Loss of Synaptic D1 Dopamine/N-Methyl-D-aspartate Glutamate Receptor Complexes in L-DOPA-Induced Dyskinesia in the Rat
Mol. Pharmacol., March 1, 2006; 69(3): 805 - 812.
[Abstract] [Full Tex